BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33769855)

  • 1. Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use.
    Parcher B; Coder M
    J Manag Care Spec Pharm; 2021 Apr; 27(4):536-538. PubMed ID: 33769855
    [No Abstract]   [Full Text] [Related]  

  • 2. Ensuring public trust in digital therapeutics: a pharmacopeial perspective.
    Ambrose M
    J Manag Care Spec Pharm; 2021 Apr; 27(4):533-535. PubMed ID: 33769853
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodology for conducting a comprehensive product review in managed care.
    Linnerooth S; Penley B; Sauvageau G; Ha J; Beal A; Craven J; Feeney E; Taddei-Allen P; Thomas N; Watkins J; Hydery T
    J Manag Care Spec Pharm; 2023 Mar; 29(3):237-243. PubMed ID: 36840955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can We Trust the Quality of Generic Drugs?
    Eban K
    J Manag Care Spec Pharm; 2020 May; 26(5):589-591. PubMed ID: 32347179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Quality of Generic Drugs Cause for Concern?
    Hussar DA
    J Manag Care Spec Pharm; 2020 May; 26(5):597-599. PubMed ID: 32347175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Physician's Perspective on Generic Drug Quality.
    Lever HM
    J Manag Care Spec Pharm; 2020 May; 26(5):592-593. PubMed ID: 32347170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Reemergence of Specialty Pharmacy.
    Vanscoy G; Seymore B; Kohli N; Patel J; Ogurchak J
    J Manag Care Spec Pharm; 2020 Mar; 26(3):234-235. PubMed ID: 32105171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indication or diagnosis should be required on prescriptions.
    Rupp MT; Warholak TL; Murcko AC
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1136-1139. PubMed ID: 34337989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving Pharmacy Benefits from Nice to Have to Essential Benefits.
    Caldwell KA; Edgar B
    J Manag Care Spec Pharm; 2020 Aug; 26(8):943-944. PubMed ID: 32715963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMCP Partnership Forum: The evolving role of digital therapeutics.
    J Manag Care Spec Pharm; 2022 Jul; 28(7):804-810. PubMed ID: 35699389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DIGITAL THERAPY TECHNOLOGIES (LITERATURE REVIEW)].
    Kravchuk AA; Aksenova EI; Kamynina NN
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 Dec; 30(s1):1038-1043. PubMed ID: 36385071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of financial medication assistance on medication adherence: a systematic review.
    Hung A; Blalock DV; Miller J; McDermott J; Wessler H; Oakes MM; Reed SD; Bosworth HB; Zullig LL
    J Manag Care Spec Pharm; 2021 Jul; 27(7):924-935. PubMed ID: 34185554
    [No Abstract]   [Full Text] [Related]  

  • 13. Schizophrenia population health management: perspectives of and lessons learned from population health decision makers.
    Roach M; Lin D; Graf M; Pednekar P; Chou JW; Benson C; Doshi JA
    J Manag Care Spec Pharm; 2021 Oct; 27(10-a Suppl):S2-S13. PubMed ID: 34652218
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Cloutier M; Guérin A; Lefebvre P
    J Manag Care Spec Pharm; 2022 Feb; 28(2):168-179. PubMed ID: 34806909
    [No Abstract]   [Full Text] [Related]  

  • 15. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
    Stull M; Gupton C
    J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal for capturing patient experience through extended value frameworks of health technologies.
    Inotai A; Jakab I; Brixner D; Campbell JD; Hawkins N; Kristensen LE; Charokopou M; Mountian I; Szegvari B; Kaló Z
    J Manag Care Spec Pharm; 2021 Jul; 27(7):936-947. PubMed ID: 34185553
    [No Abstract]   [Full Text] [Related]  

  • 17. THE MOST FAVORED NATIONS MODEL INTERIM FINAL RULE IS FATALLY FLAWED AND MUST BE RESCINDED-YET THE PROBLEM IT ADDRESSES DEMANDS A SOLUTION.
    Rubinstein E
    J Manag Care Spec Pharm; 2021 Feb; 27(2):286. PubMed ID: 33506733
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
    Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
    Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tiered Pharmacy Benefit: Challenges in Today's Health Care Market.
    Kenney JT
    J Manag Care Spec Pharm; 2020 May; 26(5):586-587. PubMed ID: 32347178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managed Care Pharmacy Research on Inappropriate Opioid Use Interventions.
    Hertzog LL; McAdam-Marx C; Happe LE
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1199-1202. PubMed ID: 32996387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.